Using surrogate end-points for clinical trials represents a massive boost for pharmaceutical company profits. So, they work hard, behind the scenes, to ensure that this happens

Much planning and setup is needed to convince the world medical treatments are effective, or even necessary in the first place.

In this presentation from 2019, Greg Glassman tells the story of how bad science, primarily in the form of corruption, led him to make business decisions to fight to protect his affiliate gyms.

Emily explains the strengths, weaknesses, and ways to interpret observational studies. These types of studies can be useful for identifying links between things, and then generating hypotheses. However, the results of any observational study are strictly corollary, and do not prove cause.

In this next video, BSI's Emily Kaplan explains all-cause mortality, and how it should be included when considering any medical treatment.

In this next part, Emily breaks down the difference between induction and deduction.

The diversion from modern science towards post-modern science began about 100 years ago. Since then things have gone from bad to worse, with bad science [...]

William Briggs examines the wildly varied outcomes produced by statistical analysts when presented identical data sets.

Dr. Malcolm Kendrick dives into history of medical breakthroughs showing us how new ideas are often shunned in order to maintain the status quo.